ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED et al v. ELI LILLY AND COMPANY
| Orbicular Pharmaceutical Technologies Private Limited and CIPLA USA, INC. |
| ELI LILLY AND COMPANY |
| 1:2022cv01130 |
| June 2, 2022 |
| US District Court for the Southern District of Indiana |
| Tim A Baker |
| Tanya Walton Pratt |
| Patent - Abbreviated New Drug Application(ANDA) |
| 28 U.S.C. ยง 1338 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 27, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 11
ORDER granting Plaintiffs' #6 MOTION to Maintain Document Under Seal. The Clerk is directed to maintain the unredacted complaint [Filing No. 5] under seal. Signed by Magistrate Judge Tim A. Baker on 6/27/2022. (SWM)
|
| Filing 10 NOTICE of Initial Filing in lawsuit sent to Director of U.S. Patent and Trademark Office. (Attachments: #1 Complaint) (AKH) |
| Filing 9 MAGISTRATE JUDGE's NOTICE of Availability to Exercise Jurisdiction issued. (JSR) |
| Filing 8 Summons Issued as to ELI LILLY AND COMPANY. (JSR) |
| Filing 7 BRIEF/MEMORANDUM in Support re #6 MOTION to Maintain Document Under Seal #5 SEALED Document (Case Participants - doc) , filed by Plaintiffs CIPLA USA, INC., Orbicular Pharmaceutical Technologies Private Limited. (Riley, James) |
| Filing 6 MOTION to Maintain Document Under Seal #5 SEALED Document (Case Participants - doc) , filed by Plaintiffs CIPLA USA, INC., Orbicular Pharmaceutical Technologies Private Limited. (Attachments: #1 Text of Proposed Order)(Riley, James) |
| Filing 5 *** SEALED PER DKT. NUMBER #11 *** SEALED , re #1 Complaint, filed by Plaintiffs CIPLA USA, INC., Orbicular Pharmaceutical Technologies Private Limited. (Attachments: #1 Exhibit A, #2 Exhibit B. 3.22.22 Listing of PIV Cert., #3 Exhibit C. Investor Presentation, #4 Exhibit D.)(Riley, James) Modified on 6/27/2022 (SWM). |
| Filing 4 Corporate Disclosure Statement by CIPLA USA, INC., Orbicular Pharmaceutical Technologies Private Limited identifying Corporate Parent INVAGEN PHARMACEUTICALS, INC. for CIPLA USA, INC... (Riley, James) |
| Filing 3 Corporate Disclosure Statement by CIPLA USA, INC., Orbicular Pharmaceutical Technologies Private Limited. (Riley, James) |
| Filing 2 NOTICE of Appearance by James W. Riley, Jr on behalf of Plaintiffs CIPLA USA, INC., Orbicular Pharmaceutical Technologies Private Limited. (Riley, James) |
| Filing 1 COMPLAINT (Redacted) against ELI LILLY AND COMPANY, filed by All Plaintiffs. (Filing fee $402, receipt number AINSDC-7130320) (Attachments: #1 Exhibit A., #2 Exhibit B. 3.22.22 Listing of PIV Cert., #3 Exhibit C. Investor Presentation, #4 Exhibit D., #5 Civil Cover Sheet, #6 Proposed Summons)(Riley, James) Modified text on 6/3/2022 (TRG). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Indiana Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
